Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PRVA
HOLDPrivia Health Group, Inc. · Healthcare · United States · $3.2B · Avg Vol: $32M/d
COMPANY DESCRIPTION
Privia Health Group operates a national physician enablement company, transforming physician practices through its proprietary technology platform and value-based care model. The company's competitive advantage lies in its ability to improve clinical outcomes and reduce costs for providers, establishing a strong network effect and sticky relationships within its physician groups.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.7B | 1.7B | 2.1B | 16.1% | 2.2B | 2.4B | 2.7B | 12.1% |
| EPS | -0.08 | 0.20 | 0.12 | 0.19 | -2.5% | 0.17 | 0.18 | 0.21 | 5.3% |
| Shares | 114.7M | 118.2M | 120.3M | 123.6M | +7.8% | 126.0M | — | — | — |
| Debt | 11.5M | 8.3M | 5.6M | 9.5M | -6.1% | 9.0M | — | — | — |
| Equity | 499.1M | 561.4M | 635.2M | 737.2M | 13.9% | — | — | — | — |
| Op CF | 47.2M | 80.8M | 109.3M | 163.4M | 51.3% | 138.0M | — | — | — |
| Inv CF | -0.1M | -43.0M | -12.0M | -181.6M | — | — | — | — | — |
| Fin CF | -19.7M | 3.7M | 4.3M | 6.7M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PRVA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PRVA | Privia Health Group, Inc.(you) | $3.2B | 59 | HOLD |
| DOCS | Doximity, Inc. | $3.7B | 62 | HOLD |
| WAY | Waystar Holding Corp. | $4.3B | 64 | HOLD |
| OMCL | Omnicell, Inc. | $1.9B | 65 | BUY |
| OMDA | Omada Health, Inc. | $1.2B | 63 | HOLD |
| CERT | Certara, Inc. | $1.2B | 53 | HOLD |
| TXG | 10x Genomics, Inc. | $5.9B | 75 | BUY |
| TDOC | Teladoc Health, Inc. | $1.6B | 76 | BUY |
| TALK | Talkspace, Inc. | $873M | 65 | HOLD |
| HNGE | Hinge Health, Inc. | $5.8B | 81 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.7%